[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 Interferon alfacon-1

Product Approval Information - Licensing Action


Proper name: Interferon alfacon-1
Tradename: Infergen
Manufacturer: Amgen, Inc, Thousand Oaks, CA, License #1080
Indication for Use: Treatment of chronic hepatitis C virus (HCV) infection in patients 18 years of age or older with compensated liver disease who have anti-HCV serum antibodies and/or the presence of HCV RNA
Approval Date: 10/6/97
Type of submission: Biologics license application


Approval Letter (PDF) (Text)

Label (PDF)

SBA (PDF)

Last Updated: 3/5/2001  

Back to Top     Back to Index

Date created: September 23, 2003

horizonal rule